HOUSE 2355117th CongressReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Opioid Prescription Verification Act of 2021

Last Action: 12/9/2021

Actions

2021-12-09Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2021-12-08Motion to reconsider laid on the table Agreed to without objection.
2021-12-08On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
2021-12-08Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422).(consideration: CR H7540-7541)
2021-11-30At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
2021-11-30DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
2021-11-30Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
2021-11-30Mr. Pallone moved to suspend the rules and pass the bill, as amended.
2021-11-30Placed on the Union Calendar, Calendar No. 130.
2021-11-30Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
2021-11-30Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
2021-07-21Ordered to be Reported (Amended) by Voice Vote.
2021-07-21Committee Consideration and Mark-up Session Held.
2021-07-15Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
2021-07-15Subcommittee Consideration and Mark-up Session Held.

Showing 15 of 19 actions. Full history on Congress.gov.

CRS Summary

As of 2021-12-08 (53)

Opioid Prescription Verification Act of 2021

This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).

Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.

In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that

maintain a prescription drug monitoring program that mandates the collection of specified information,
require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.

Cosponsors (8)

Gus Bilirakis (R-FL)
Ann Wagner (R-MO)
Michael Turner (R-OH)
Adam Kinzinger (R-IL)
Alexander Mooney (R-WV)
C. Franklin (R-FL)
Doug LaMalfa (R-CA)
Ted Budd (R-NC)

Subjects

Business records
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Health information and medical records
Health personnel
Health programs administration and funding
Photography and imaging
Prescription drugs
Retail and wholesale trades

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.